TITLE

Web resources and treatment of TB

AUTHOR(S)
Barnard, Keith
PUB. DATE
July 2006
SOURCE
GP: General Practitioner;7/14/2006, p22
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
This article presents information on websites that provide information for the treatment of tuberculosis. One of the websites named www.ersnet.org provides information about the treatment of tuberculosis without side effects. It discusses the side-effects of the various drugs. It also informs about a symptom-based approach to the management of both minor and major side-effects. Another website www.cmo.wales.gov.uk explains the BCG vaccination. It starts with explaining what TB is, how it is transmitted and the symptoms that occur. Yet another website www.HomeHerbs.com presents information on the herbal treatment of tuberculosis.
ACCESSION #
21748705

 

Related Articles

  • Roles of rifampicin in drug-drug interactions: underlying molecular mechanisms involving the nuclear pregnane X receptor. Jiezhong Chen; Raymond, Kenneth // Annals of Clinical Microbiology & Antimicrobials;2006, Vol. 5, p3 

    Rifampicin, an important drug in the treatment of tuberculosis, is used extensively despite its broad effects on drug-drug interactions, creating serious problems. The clinical importance of such interactions includes autoinduction leading to suboptimal or failed treatment. The concomitantly...

  • ETHIONAMIDE.  // Complete Guide to Prescription & Nonprescription Drugs 2012;2007, p370 

    The article presents information on ethionamide, an antimycobacterial agent used for the treatment of tuberculosis. The dosage and usage information is provided. The possible adverse reactions or side effects of the drug, warnings, and precautions are discussed. Possible interaction of the drug...

  • ETHIONAMIDE.  // Complete Guide to Prescription & Nonprescription Drugs 2012;2008, p372 

    The article presents information on ethionamide, an antimycobacterial agent used for the treatment of tuberculosis. The dosage and usage information is provided. The possible adverse reactions or side effects of the drug, warnings, and precautions are discussed. Possible interaction of the drug...

  • HIV-Associated Tuberculosis: Clinical Update. Swaminathan, Soumya; Padmapriyadarsini, C.; Narendran, G. // Clinical Infectious Diseases;5/15/2010, Vol. 50 Issue 10, p1377 

    The human immunodeficiency virus (HIV) epidemic has led to an increase in the incidence of tuberculosis globally, particularly in sub-Saharan Africa. Coinfection with HIV leads to difficulties in both the diagnosis and treatment of tuberculosis. Because of the poor performance of sputum smear...

  • AdverseEvents Launches Innovative Comparative Drug Side Effect Reporting System at Health 2.0 Conference.  // Biomedical Market Newsletter;9/30/2011, Vol. 21, p656 

    The article reports on the launch of AdverseEvents Inc.'s (AEI) comparative drug side effect reporting system. It reveals that the system is a website that delivers accurate, real-time information on adverse drug events. In addition, users will have the ability to quantify and understand the...

  • Yellow card drug data to be released online. Polak, Monika // GP: General Practitioner;3/8/2004, p14 

    Suspected adverse drug reaction (ADR) data collected through the yellow card scheme will be made available online. However, there will be restrictions on access, according to the chairman of the steering group leading the review of the scheme. Former deputy chief medical officer Jeremy Metters...

  • Adverse drug reactions. McCombs, Barrie // Canadian Journal of Rural Medicine (Joule Inc.);Winter2006 Supplement, Vol. 11, p131 

    The article features the new website of Health Canada, which facilitates information about adverse drug reactions for rural physicians and about certain events in their own practice. The MedEffect.Ca website has a home page that links to topics, including adverse reaction database, information...

  • Adverse reaction reporting in Canada.  // WHO Drug Information;2007, Vol. 21 Issue 3, p197 

    The article reports that Health Canada has developed two new online educational modules on adverse reaction (AR) reporting of marketed health products. It included, Health Professional Reporting of Adverse (Drug) Reactions and Reporting Side Effects from Your Medicine: What You Need to Know. It...

  • First drug approved specifically for multi-drug resistant tuberculosis. Sobieraj, Diana M. // Drug Topics;Mar2013, Vol. 157 Issue 3, p44 

    The article looks into the efficacy, safety and recommended dosage of bedaquiline tablets, the first drug approved by the U.S. Food and Drug Administration (FDA) specifically for the treatment of pulmonary multi-drug resistant tuberculosis (MDR-TB) as part of combination therapy in adults. It...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics